Stockreport

4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Entered strategic partnership with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of 4D-150 in the APAC region; to receive $85 million in upf [Read more]